# Tigecycline

NDC: 55150-228
Generic name: Tigecycline
Labeler / Manufacturer: Eugia US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190611

FDA application: ANDA206335

## Active ingredients

- TIGECYCLINE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-228"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-228
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd58e0c3-d8a8-4cf2-96f8-9dd08f309579